Emeis share rebounds and posts one of the best gains on the SBF 120
The accommodation and care group rebounded this Thursday, posting one of the best performances on the SBF 120 in an index slightly in the red. This recovery occurs in a market context weakened by geopolitical tensions in the Middle East and rising bond yields.
A rebound of 2.35% that contrasts with a slightly declining SBF 120
Emeis gains 2.35% to €13.05 during the session, ranking among the strongest gainers on the SBF 120 while the broad index falls 0.14%. This rebound follows a marked decline in recent weeks: the stock still shows a decline of 10.37% over one month and 3.69% over the week, illustrating persistent pressure since last summer. The brief published Wednesday reported a stock threatening its support level of €12.66; the price ultimately moved away from it, regaining ground without however breaking through a decisive technical threshold. Over one year, the gain remains substantial at +15.08%, which puts the recent correction into perspective within a fundamentally positive trajectory.
Moving averages still above the price, RSI close to oversold
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Despite this rebound, Emeis remains well below its three moving averages: the 20-day MA at €13.80, the 50-day MA at €14.01 and the 200-day MA at €14.04 all weigh above the current price, with gaps ranging between 5.4% and 7%. These levels form a coherent technical ceiling, and the resistance identified at €14.56 is located even further away. The RSI at 35 reflects a configuration close to oversold, which may signal short-term selling exhaustion without necessarily validating a trend reversal.
On the fundamental side, Q1 2026 results published on May 7 showed organic growth of 6.3%, driven by improving occupancy rates. Resistance at €14.56 constitutes the next level to watch to validate a more sustainable recovery.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.